Medication

Weight loss drugs come with some problems for patients

Editor’s Note: The following is part of a group project that began in Ball State University professor Adam Kuban’s classroom in the fall of 2021. Kuban continued the project this spring semester, challenging his students to find sustained effort. in the Muncie area and voice their opinions. to Ron Wilkins, interim editor of The Star Press, Journal & Courier and Palladium-Item. This semester, stories related to health care are presented.

MUNCIE, Ind. – Weight loss solutions have undergone a revolution in recent years with injectable drugs that target obesity. In this evolution, consumers have become familiar with Semaglutide products with promising weight loss goals.

Ozempic, made from the drug Semaglutide and originally developed for the treatment of type 2 diabetes, has gained attention for its impressive weight loss results when used in high doses. .

Dr.  Srinivasu Kesa works at MD Wellness & Med Spa, where his vision is to provide a facility of

According to the FDA, Ozempic helps lower blood sugar while stimulating the body to produce more insulin. The drug works by interacting with the part of the brain that signals satiety as well as reducing appetite.

Currently, only three Semaglutide injections are approved by the FDA.

#Weight #loss #drugs #problems #patients

Leave a Reply

Your email address will not be published. Required fields are marked *